Autonomix Medical, Inc. (AMIX)
$4.21+$0.00 (+0.00%) Latest session
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 53,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
8 Form 4 filings on record, the earliest from Aug 11, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Walter V. Klemp - Director | Grant or award | Common Stock | 13,000 | - | - | |
| Lori Bisson - Director | Grant or award | Common Stock | 13,000 | - | - | |
| Bradley Hauser - Officer | Grant or award | Common Stock | 27,000 | - | - | |
| Walter V. Klemp - Director | Derivative | Option (Right to buy) | 8,773 | - | - | |
| Trent N. Smith - Officer | Derivative | Option (Right to buy) | 11,405 | - | - | |
| Trent N. Smith - Officer | Derivative | Option (Right to buy) | 21,250 | - | - | |
| Lori Bisson - Director | Derivative | Option (Right to buy) | 18,862 | - | - | |
| Lori Bisson - Director | Derivative | Option (Right to buy) | 46,680 | - | - | |
| Christopher Capelli - Director | Derivative | Option (Right to buy) | 3,750 | - | - | |
| Bradley Hauser - Officer | Derivative | Option (Right to buy) | 45,000 | - | - |
Autonomix Medical, Inc. (AMIX) had 3 insider filings in the last 90 days, with the most recent on 2026-09-08. The full record for AMIX runs to 8 Form 4 filings, the earliest from 2025-08-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AMIX were filed in the last 90 days.
No insider sales of AMIX were filed in the last 90 days.
This page tracks AMIX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AMIX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
